LAEKNA INC
(HKEX: 2105)
Laekna, Inc. engages in the clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
9.010 -
-0.090
(-0.99%)
Range
8.840 - 9.310
(5.32%)
Open
9.210
Previous Close
9.100
Bid Price
9.000
Bid Volume
('000)
1
Ask Price
9.010
Ask Volume
('000)
67.5
Volume
('000)
5,184.5
Value
47,178,243
Remark
-
Delayed prices. Updated at 20 Dec 2024 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
